Press release
Myasthenia Gravis - Drug Pipeline Landscape, 2022
Myasthenia Gravis - Drug Pipeline Landscape
Healthcare professional checks neurological health by testing reflexes, muscle strength, muscle tone etc. Ice pack test, antibody tests, imaging scans and electromyogram can also be used for diagnosis. Myasthenia gravis treatments include medications, monoclonal antibodies, iv immunoglobulin (ivig), plasma exchange (plasmapheresis) and surgery. The companies active in development of Myasthenia Gravis Drugs are Ahead Therapeutics, Alexion Pharmaceuticals, AnTolRx, Argenx, Cabaletta Bio etc.
Read more about Myasthenia Gravis - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/myasthenia-gravis-drug-pipeline-landscape-2022/
Report Highlights
Global Insight Service's, Myasthenia Gravis - Drug Pipeline Landscape, 2022 report provides an overview of the Myasthenia gravis pipeline drugs. This report covers detailed insights on Myasthenia Gravis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Myasthenia Gravis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31033/
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Key Players:
- Ahead Therapeutics
- Alexion Pharmaceuticals
- AnTolRx
- Argenx
- Cabaletta Bio
- Cartesian Therapeutics
- Catalyst Pharmaceuticals, Inc.
- CSL Behring
Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31033/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myasthenia Gravis - Drug Pipeline Landscape, 2022 here
News-ID: 2700519 • Views: …
More Releases from Global Insight Services
Log Management Market Is Anticipated To Expand From $3.1 Billion In 2024 To $10. …
Market Overview
The Log Management Market has become a cornerstone of modern IT and cybersecurity strategies. With enterprises generating vast amounts of log data from applications, networks, and cloud platforms, managing this information has never been more critical. Log management solutions are designed to collect, monitor, store, and analyze these logs, helping businesses improve security, comply with regulations, and optimize performance. As organizations face rising cyber threats and increasingly complex IT…
Occupational Health Market Is Anticipated To Expand From $4.5 Billion In 2024 To …
Market Overview
The Occupational Health Market is gaining strong momentum as organizations increasingly recognize the importance of workplace safety, regulatory compliance, and employee well-being. Estimated at $4.5 billion in 2024, the market is projected to nearly double and reach $8.9 billion by 2034, reflecting a steady CAGR of 7.1%. This sector encompasses a wide range of services, solutions, and technologies, including preventive health assessments, ergonomic solutions, compliance training, wellness programs, and…
Clinical Trial Imaging Market Projected to Reach $2.8 Billion by 2034, Driven by …
The Clinical Trial Imaging Market is playing a vital role in shaping the future of drug development and patient care. It integrates cutting-edge imaging modalities such as MRI, CT, PET, and ultrasound into clinical trials, enabling researchers to collect precise data and monitor treatment efficacy with accuracy. These imaging solutions are indispensable for pharmaceutical and biotechnology companies as they help in regulatory compliance and accelerate the path from laboratory research…
Water Taxi Market to Expand from $23 Billion in 2024 to $32.1 Billion by 2034 at …
The Water Taxi Market is becoming a crucial component of modern urban and coastal transportation systems. Designed to provide efficient and scenic travel, water taxis offer commuters and tourists a practical alternative to congested roadways. From small boats to larger ferries, the industry is redefining the way people experience mobility in waterfront cities. With growing concerns about urban congestion, environmental sustainability, and tourism-driven demand, the Water Taxi Market is experiencing…
More Releases for Myasthenia
Myasthenia Gravis (MG) Treatment Market: Insights and Trends
The Global Myasthenia Gravis (MG) Treatment Market is experiencing notable growth, driven by increasing awareness of the disease and advancements in treatment options. Myasthenia Gravis is a chronic autoimmune disorder that leads to varying degrees of muscle weakness, and effective management is crucial for improving patient quality of life.
With ongoing research and development in treatment modalities, the market is poised for significant expansion over the coming years.
Market Size and Growth:
The…
Myasthenia Gravis Market | Rising Prevalence Of Neuromuscular Disorders
According to Precision Business Insights (PBI), the latest report, the Myasthenia Gravis market is expected to be valued at USD 1,734.6 million in 2022, growing at an 8.1% CAGR from 2022 to 2028. The primary driver of the expansion of the global Myasthenia Gravis market increasing prevalence of neuromuscular disorders, and rising awareness about effective treatment.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/myasthenia-gravis-market/
Medication Segment to Dominate the Myasthenia…
Myasthenia Gravis Industry Report Analysis By opportunities
Stratistics MRC's Myasthenia Gravis Market report provides readers with an understanding of market details, overview, drivers and segmentation with types.
Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis.
Browse complete "Myasthenia Gravis Market" report with TOC…
Myasthenia Gravis Industry Report Analysis By opportunities
Stratistics MRC's Myasthenia Gravis Market report provides readers with an understanding of market details, overview, drivers and segmentation with types.
Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis.
Browse complete "Myasthenia Gravis Market" report with TOC…
Global Myasthenia Gravis Industry Analysis By Geography
Stratistics MRC's Myasthenia Gravis Market report explains company profiling, key segments, market trends, top players and regional, country-level segments.
Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis.
Browse complete "Myasthenia Gravis Market" report with TOC @…
Global Myasthenia Gravis Industry Report Top 5 Players
Stratistics MRCs 2021 Myasthenia Gravis Market Report Key players include - Medtronic Plc., Novartis AG, Koninklijke Philips N.V., Pfizer Inc., Baxter International.
Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis.
Browse complete "Myasthenia Gravis Market" report…
